GlaxoSmithKline Pharmaceuticals reports marginal rise in Q4 net profit

19 Feb 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for fourth quarter ended December 31, 2012.

The company has reported 1.29% rise in its net profit at Rs 138.51 crore for the quarter as compared to Rs 136.74 crore for the same quarter in the previous year. Total income of the company has increased by 13.74% at Rs 704.34 crore for quarter under review as compared to Rs 619.25 crore for the quarter ended December 31, 2011.

For the entire 2012 fiscal, the company’s net profit surged 34.06% to Rs 577.26 crore from Rs 430.60 crore in the previous fiscal. The total income from operations went up by 11.37% to Rs 2823.78 crore from Rs 2535.50 crore in last year.

For the entire fiscal, the company’s consolidated net profit rose 31.10% to Rs 561.88 crore from Rs 428.58 crore in the previous fiscal. The total consolidated income of the company went up by 10.36% to Rs 2824.85 crore from Rs 2559.67 crore in last year.

Glaxosmithkline Phar Share Price

2543.40 0.30 (0.01%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×